100
Participants
Start Date
December 24, 2021
Primary Completion Date
July 31, 2023
Study Completion Date
August 31, 2023
ANG-3070
Orally administered tyrosine kinase inhibitor capsule
Placebo
Orally administered placebo capsule
RECRUITING
John Hunter Hospital, New Lambton
RECRUITING
Nepean Hospital, Kingswood
RECRUITING
Western Hospital, Saint Albans
RECRUITING
St Vincent's Hospital Melbourne, Fitzroy
RECRUITING
Austin Health, Melbourne
RECRUITING
Princess Alexandra Hospital, Woolloongabba
RECRUITING
"JSC Evex Hospitals", Kutaisi
NOT_YET_RECRUITING
NYU Langone Nephrology Associates, Mineola
NOT_YET_RECRUITING
University of Pennsylvania, Philadelphia
NOT_YET_RECRUITING
The Johns Hopkins Hospital, Baltimore
RECRUITING
Davita Clinical Research, Columbus
RECRUITING
South Florida Research Institute, Lauderdale Lakes
RECRUITING
Genesis Clinical Research LLC, Tampa
NOT_YET_RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Davita Clinical Research, Edina
RECRUITING
Frenova Renal Research/Nephrology and Hypertension Specialists, St Louis
RECRUITING
St. Louis Kidney Care, St Louis
RECRUITING
Clinical Research Consultants, LLC., Kansas City
NOT_YET_RECRUITING
Prolato Clinical Research Center, Houston
RECRUITING
Amicis Reserach Center, Northridge
RECRUITING
Amicis Reserach Center, Northridge
RECRUITING
Amicis Reserach Center, Vacaville
NOT_YET_RECRUITING
Massachusetts General Hospital, Boston
NOT_YET_RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
New Jersey Kidney Care, Jersey City
NOT_YET_RECRUITING
University of Vermont Medical Center, Burlington
RECRUITING
LtD Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi
RECRUITING
"Tbilisi State Medical University's and Ingorokva's University Clinic of High Medical Technologies LTD", Tbilisi
RECRUITING
Ivane Bokeria Tbilisi Referral Hospital, Tbilisi
RECRUITING
Tbilisi Heart Center, Tbilisi
Lead Sponsor
Angion Biomedica Corp
INDUSTRY